Early Left Ventricular Dysfunction and Severe Pulmonary Hypertension Predict Adverse Outcomes in "Low-Risk"

Duy T Dao1,2, Neil Patel3, Matthew T Harting4

  • 1Department of Surgery, Boston Children's Hospital, Boston, MA.

Insights

Early cardiac dysfunction and pulmonary hypertension predict adverse outcomes in low-risk congenital diaphragmatic hernia (CDH) infants. Identifying these risk factors can guide interventions to improve survival in this population.

Area of Science:

  • Pediatric Cardiology
  • Neonatal Surgery
  • Critical Care Medicine

Background:

  • Congenital diaphragmatic hernia (CDH) management often prioritizes high-risk cases.
  • Risk factors for adverse outcomes in "low-risk" CDH populations require further identification.
  • Early cardiac dysfunction and pulmonary hypertension are potential predictors of poor outcomes.

Purpose of the Study:

  • To identify risk factors for suboptimal outcomes in "low-risk" congenital diaphragmatic hernia (CDH) infants.
  • To investigate the association between early cardiac dysfunction, pulmonary hypertension, and adverse events in this cohort.

Main Methods:

  • Retrospective cohort study using the Congenital Diaphragmatic Hernia Study Group registry.
  • Defined "low-risk" CDH as defect size A/B without cardiac or chromosomal anomalies.
  • Analyzed left ventricular dysfunction, right ventricular dysfunction, and severe pulmonary hypertension on postnatal echocardiograms as risk factors for composite adverse events.

Main Results:

  • Seven hundred seventy-eight "low-risk" CDH infants were analyzed.
  • Left ventricular dysfunction (10.8%), right ventricular dysfunction (20.5%), and severe pulmonary hypertension (57.5%) were present.
  • Left ventricular dysfunction and severe pulmonary hypertension independently predicted adverse outcomes (composite events including death, ECMO, prolonged oxygen, or extended hospitalization).

Conclusions:

  • Early left ventricular dysfunction and severe pulmonary hypertension are significant predictors of adverse outcomes in "low-risk" CDH infants.
  • These findings highlight the need for early recognition and intervention in this specific patient group.
  • Improved outcomes may be achievable through targeted interventions based on early echocardiographic findings.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
309
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
300
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
297
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
269
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
601
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
361